Trice Medical Inc. closed a series C financing round, raising $19.3 million.

The company will use proceeds to accelerate and expand the company's U.S. market penetration for its mi-eye 2 technology.

The mi-eye 2 is a disposable needle with a wide-angle camera that allows physicians to diagnose joint injuries from the doctor's office.

Trice Medical has raised $40.9 million to date, including the series C financing round, which saw Smith & Nephew PLC take a minority stake in the company.